These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18541113)

  • 1. Recent advances in the genetics of dementia with lewy bodies.
    Bonifati V
    Curr Neurol Neurosci Rep; 2008 May; 8(3):187-9. PubMed ID: 18541113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 variation and dementia with Lewy bodies.
    Heckman MG; Soto-Ortolaza AI; Contreras MYS; Murray ME; Pedraza O; Diehl NN; Walton R; Labbé C; Lorenzo-Betancor O; Uitti RJ; van Gerpen J; Ertekin-Taner N; Smith GE; Kantarci K; Savica R; Jones DT; Graff-Radford J; Knopman DS; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Rademakers R; Wszolek ZK; Graff-Radford NR; Ferman TJ; Dickson DW; Boeve BF; Ross OA
    Parkinsonism Relat Disord; 2016 Oct; 31():98-103. PubMed ID: 27521182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lrrk2 interaction with alpha-synuclein in diffuse Lewy body disease.
    Qing H; Zhang Y; Deng Y; McGeer EG; McGeer PL
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1229-34. PubMed ID: 19878656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.
    Lerche S; Machetanz G; Wurster I; Roeben B; Zimmermann M; Pilotto A; Preische O; Stransky E; Deuschle C; Hauser AK; Schulte C; Lachmann I; Waniek K; Gasser T; Berg D; Maetzler W; Brockmann K
    Mov Disord; 2019 Jul; 34(7):1069-1073. PubMed ID: 31189032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of Parkinson's syndromes: a critical review.
    Hardy J; Lewis P; Revesz T; Lees A; Paisan-Ruiz C
    Curr Opin Genet Dev; 2009 Jun; 19(3):254-65. PubMed ID: 19419854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.
    Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T
    Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive genetic and mutation analysis of familial dementia with Lewy bodies linked to 2q35-q36.
    Meeus B; Nuytemans K; Crosiers D; Engelborghs S; Peeters K; Mattheijssens M; Elinck E; Corsmit E; De Deyn PP; Van Broeckhoven C; Theuns J
    J Alzheimers Dis; 2010; 20(1):197-205. PubMed ID: 20164589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of Parkinson's disease.
    Morris HR
    Ann Med; 2005; 37(2):86-96. PubMed ID: 16026116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the link between GBA1 mutations and Dementia with Lewy bodies, A mini-review.
    Gaubert S; Hourregue C; Mouton-Liger F; Millot P; Franco M; Amar-Bouaziz E; Aarsland D; Hugon J; Paquet C
    Neurosci Biobehav Rev; 2022 Oct; 141():104856. PubMed ID: 36084847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions.
    Walker L; Stefanis L; Attems J
    J Neurochem; 2019 Sep; 150(5):467-474. PubMed ID: 30892688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies.
    Gámez-Valero A; Prada-Dacasa P; Santos C; Adame-Castillo C; Campdelacreu J; Reñé R; Gascón-Bayarri J; Ispierto L; Álvarez R; Ariza A; Beyer K
    Mov Disord; 2016 Jul; 31(7):1066-70. PubMed ID: 27027900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.
    Yang NY; Lee YN; Lee HJ; Kim YS; Lee SJ
    Biol Chem; 2013 Jul; 394(7):807-18. PubMed ID: 23435096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
    Nalls MA; Duran R; Lopez G; Kurzawa-Akanbi M; McKeith IG; Chinnery PF; Morris CM; Theuns J; Crosiers D; Cras P; Engelborghs S; De Deyn PP; Van Broeckhoven C; Mann DM; Snowden J; Pickering-Brown S; Halliwell N; Davidson Y; Gibbons L; Harris J; Sheerin UM; Bras J; Hardy J; Clark L; Marder K; Honig LS; Berg D; Maetzler W; Brockmann K; Gasser T; Novellino F; Quattrone A; Annesi G; De Marco EV; Rogaeva E; Masellis M; Black SE; Bilbao JM; Foroud T; Ghetti B; Nichols WC; Pankratz N; Halliday G; Lesage S; Klebe S; Durr A; Duyckaerts C; Brice A; Giasson BI; Trojanowski JQ; Hurtig HI; Tayebi N; Landazabal C; Knight MA; Keller M; Singleton AB; Wolfsberg TG; Sidransky E
    JAMA Neurol; 2013 Jun; 70(6):727-35. PubMed ID: 23588557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?
    Gámez-Valero A; Canet-Pons J; Urbizu A; Anillo A; Santos C; Ariza A; Beyer K
    J Alzheimers Dis; 2018; 65(1):207-219. PubMed ID: 30040713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits.
    Wurtman RJ
    Metabolism; 2013 Jan; 62 Suppl 1():S27-9. PubMed ID: 22999712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder.
    Bogaerts V; Engelborghs S; Kumar-Singh S; Goossens D; Pickut B; van der Zee J; Sleegers K; Peeters K; Martin JJ; Del-Favero J; Gasser T; Dickson DW; Wszolek ZK; De Deyn PP; Theuns J; Van Broeckhoven C
    Brain; 2007 Sep; 130(Pt 9):2277-91. PubMed ID: 17681982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions.
    Orme T; Guerreiro R; Bras J
    Curr Neurol Neurosci Rep; 2018 Aug; 18(10):67. PubMed ID: 30097731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticipation of onset age in familial Parkinson's disease without SCA gene mutations.
    Huang Y; Hayes M; Harding AJ; Brooks WS; Fung VS; Rowe D; Joffe R; Crimmins D; Hely M; Halliday GM
    Parkinsonism Relat Disord; 2006 Jun; 12(5):309-13. PubMed ID: 16621662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant Parkinson's disease and the route to new therapies.
    Morris HR
    Expert Rev Neurother; 2007 Jun; 7(6):649-56. PubMed ID: 17563248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are genetic and sporadic Parkinson's disease patients equally susceptible to develop dementia?
    Inzelberg R; Polyniki A
    J Neurol Sci; 2010 Feb; 289(1-2):23-6. PubMed ID: 19740488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.